ArticleCurrent therapeutic research, clinical and experimental2024

US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 Patients.

Mark R Cullen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.